The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

In an interview with Peers & Perspectives in Oncology, Sherry Shen, MD, discusses the GLP-1 agonists analyzed for weight ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...

Metsera plans to initiate a Phase 2b trial of MET-097 in Q4 2024, with data anticipated in the first half of 2025.

Skye launched its Phase 2 trial of nimacimab in obesity in August 2024. This trial, which is the first to also assess a GLP-1/CB1 inhibitor combination, is expected to report interim weight loss data ...

In addition, 25 g of dietary fiber, one tablet of multivitamins, and 1 g of omega-3 with 2000 IU of vitamin D per day were recommended to avoid essential nutrient deficiency during the weight-loss ...

Cachexia is a wasting syndrome prevalent in cancer patients (as well as patients with other conditions) that is marked by ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...